Distinct physiological, transcriptomic, and imaging characteristics of asthma-COPD overlap compared to asthma and COPD in smokers
This work was supported by National Heart, Lung, and Blood Institute (NHLBI) grants U01 HL089897 and U01 HL089856, as well as by National Institutes of Health (NIH) contract 75N92023D00011. Additional support was provided by grants R01 HL166231 (C.P.H.) and K01 HL157613 (A.S.).
Authors
- Aabida Saferali (ORCID: https://orcid.org/0000-0001-6399-0249)
- Peter J. Castaldi (ORCID: https://orcid.org/0000-0001-9920-4713)
- Craig P. Hersh (ORCID: https://orcid.org/0000-0002-1342-4334)
- Scott T. Weiss (ORCID: https://orcid.org/0000-0001-7196-303X)
- Vrushali D Fangal
Institutions
- Brigham and Women's Hospital (US)
Publication Details
- Journal
- EBioMedicine
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1016/j.ebiom.2024.105453
- Citations
- 14
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 5.87
Funders
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- COPD Foundation
- Sunovion
- National Institutes of Health
- Genentech
- National Heart, Lung, and Blood Institute